Lopinavir

CAS 192725-17-0 9 current records 4 historicalSmall Molecule

Who holds supplier records for Lopinavir? 9 organisations hold a current record for Lopinavir: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Lopinavir: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lopinavir

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lopinavir. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Lopinavir sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Lopinavir, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
LAURUS LABS LIMITED HyderabadIN
CEP 2020-103 - Rev 02
Lopinavir, Type I higher hydrated crystal form
Oct 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2013-011 - Rev 04
Lopinavir
Sept 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2018-071 - Rev 01
Lopinavir
Feb 2024—
HETERO DRUGS LIMITED HyderabadIN
R0-CEP 2020-396 - Rev 00
Lopinavir
Oct 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Lopinavir are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • India · Inactive DMF 23256 · filed Nov 2009
  • RANBAXY LABORATORIES LTD
    Inactive DMF 21101 · filed Dec 2007
  • MATRIX LABORATORIES LTD
    Inactive DMF 20756 · filed Aug 2007
  • MYLAN LABORATORIES LTD
    Inactive DMF 19600 · filed Jul 2006

Overview

Lopinavir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL729).

Chemical identity

IUPAC name
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
Canonical SMILES
CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O
InChIKey
KJHKTHWMRKYKJE-SUGCFTRWSA-N
Synonyms
A-157378-0, A-157378.0, ABT-378, Aluviran, Koletra, Lopinavir, Lopinavir-, Lopinavir component of kaletra, Lopinavir, (s-(2s,4s,5s))-, Lopinavirum, A 157378.0, CHEBI:31781

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lopinavir?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Lopinavir: Hetero Labs Limited (India), Shanghai Desano Chemical Pharmaceutical Co., Ltd (China), APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), Laurus Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), ACEBRIGHT INDIA PHARMA PRIVATE LTD (India) and Arene Life Sciences Limited (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lopinavir Drug Master Files are active?

Hetero Labs Limited (DMF 19852, 30636), Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 30154, 34144), APITORIA PHARMA PRIVATE LTD (DMF 19862), Hetero Drugs Limited (DMF 26303), Laurus Labs Limited (DMF 33919), MATRIX PHARMACORP PRIVATE LTD (DMF 20363), ACEBRIGHT INDIA PHARMA PRIVATE LTD (DMF 28244) and Arene Life Sciences Limited (DMF 34744) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Lopinavir records mean?

4 organisations have only inactive Type II DMFs for Lopinavir. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Lopinavir have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Lopinavir on the EDQM register, including LAURUS LABS LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and HETERO DRUGS LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Lopinavir supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lopinavir?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.